Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Explore clinical trials studying Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group) trial results

Completed

Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

NCT05226702

Conditions: Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group), Double Vaccinated for COVID-19 (For Phase 1 of the Study)
Locations: Manna Research (Burlington North) Burlington, Ontario, Canada

Manna Research Toronto, Ontario, Canada

Canadian Center for Vaccinology Saskatoon, Saskatchewan, Canada

View Trial Details

Double Vaccinated for COVID-19 (For Phase 1 of the Study) (1)

Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group) trial results

Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

Related conditions